The story of Viagra, initially marketed by copyright, presents a intricate case study for investors considering the healthcare sector. While its groundbreaking success and impact of countless in sales, the patent lapse has opened the door for alternative medications, significantly reducing profit prospects . This change raises concerns about the fu